{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T09:16:37Z","timestamp":1781860597516,"version":"3.54.5"},"reference-count":23,"publisher":"Gobierno de Navarra","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An Sist Sanit Navar"],"published-print":{"date-parts":[[2020,4,20]]},"DOI":"10.23938\/assn.0756","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T08:25:09Z","timestamp":1583483109000},"page":"43-49","source":"Crossref","is-referenced-by-count":4,"title":["Juvenile myoclonic epilepsy: long-term prognosis and antiepileptic drug withdrawal"],"prefix":"10.23938","volume":"43","member":"10024","reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/BF00242439","article-title":"Impulsiv petit mal","volume":"176","author":"JANZ","year":"1957","unstructured":"1. JANZ D, CHRISTIAN W. Impulsiv petit mal. Dtsch Z Nervenheilkd 1957; 176: 346-386.","journal-title":"Dtsch Z Nervenheilkd"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. DE ARA\u00daJO FILHO GM, YACUBIAN EM. Juvenile myoclonic epilepsy: psychiatric comorbididty and impact on outcome. Epilepsy Behav 2013; 28 (Suppl 1):74-80. https:\/\/doi.org\/10.1016\/j.yebeh.2013.03.026","DOI":"10.1016\/j.yebeh.2013.03.026"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. WANDSCHNEIDER B, THOMPSON PJ, VOLLMAR C, KOEPP MJ. Frontal lobe function and structure in juvenile myoclonic epilepsy: a comprehensive review of neuropsychological and imaging data. Epilepsia 2012; 53: 2091-2098. https:\/\/doi.org\/10.1111\/epi.12003","DOI":"10.1111\/epi.12003"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. MART\u00cdNEZ-DOM\u00cdNGUEZ S, LABRADA-ABELLA J, PEDR\u00d3S-ROSELL\u00d3 A, L\u00d3PEZ-GOM\u00c1RIZ E, TEN\u00cdAS-BURILLO JM. Enfermedad mental, rasgos de personalidad y calidad de vida en epilepsia: estudio control de pacientes con epilepsia miocl\u00f3nica juvenil y otras epilepsias. Rev Neurol 2013; 56: 608-614. https:\/\/doi.org\/10.33588\/rn.5612.2013181","DOI":"10.33588\/rn.5612.2013181"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. WOLF P, TARGAS YACUBIAN EM, AVANZINI G, SANDER T, SCHMITZ B, WANDSCHNEIDER B et al. Juvenile myoclonic epilepsy: a system disorder of the brain. Epilepsy Res 2015; 114: 2-12. https:\/\/doi.org\/10.1016\/j.eplepsyres.2015.04.008","DOI":"10.1016\/j.eplepsyres.2015.04.008"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. DELGADO-ESCUETA AV, ENRILE-BACSAL F. Juvenile myoclonic epilepsy of Janz. Neurology 1984; 34: 285-294. https:\/\/doi.org\/10.1212\/wnl.34.3.285","DOI":"10.1212\/WNL.34.3.285"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. H\u00d6FFLER J, UNTERBERGER I, DOBESBERGER J, KUCHUKHIDZE G, WALSER G, TRINKA E. Seizure outcome in 175 patients with juvenile myoclonic epilepsy - A long-term observational study. Epilepsy Res 2014; 108: 1817-1824. https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.09.008","DOI":"10.1016\/j.eplepsyres.2014.09.008"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. SENF P, SCHMITZ B, HOLTKAMP M, JANZ D. Prognosis of juvenile myoclonic epilepsy 45 years after onset. Neurology 2013; 81: 2128-2133. https:\/\/doi.org\/10.1212\/01.wnl.0000437303.36064.f8","DOI":"10.1212\/01.wnl.0000437303.36064.f8"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. CAMFIELD CS, CAMFIELD PR. Juvenile myoclonic epilepsy 25 years after seizure onset. Neurology 2009; 73: 1041-1045. https:\/\/doi.org\/10.1212\/wnl.0b013e3181b9c86f","DOI":"10.1212\/WNL.0b013e3181b9c86f"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. BAYKAN B, ALTINDAG EA, BEBEK N, OZTURK AI, ASLANTAS B, GURSES C et al. Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy. Neurology 2008; 70: 2123-2129. https:\/\/doi.org\/10.1212\/01.wnl.0000313148.34629.1d","DOI":"10.1212\/01.wnl.0000313148.34629.1d"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. GEITHNER J, SCHNEIDER F, WANG Z, BERNEISER J, HERZER R, KESSLER C et al. Predictors for long-term seizure outome in juvenile myoclonic epilepsy: 25-63 years of follow-up. Epilepsia 2012; 53: 1379-1386. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03526.x","DOI":"10.1111\/j.1528-1167.2012.03526.x"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. SYVERTSEN MR, THUVE S, STORDRANGE BS, BRODTKORB E. Clinical heterogeneity of juvenile myoclonic epilepsy: follow-up after an interval of more than 20 years. Seizure 2014; 23: 344-348. https:\/\/doi.org\/10.1016\/j.seizure.2014.01.012","DOI":"10.1016\/j.seizure.2014.01.012"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. BARTOLINI L, MAJIDI S, KOUBEISSI MZ. Uncertainties from a worldwide survey on antiepileptic drug withdrawal after seizure remission. Neurol Clin Pract 2018; 8: 1-8. https:\/\/doi.org\/10.1212\/cpj.0000000000000441","DOI":"10.1212\/CPJ.0000000000000441"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Commission on Classification and Terminology of the International League against Epilepsy (ILAE). Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-399. https:\/\/doi.org\/10.1111\/j.1528-1157.1989.tb05316.x","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. PANAYIOTOPOULOS CP, OBEID T, TAHAN AR. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia 1994; 35: 285-296. https:\/\/doi.org\/10.1111\/j.1528-1157.1989.tb05316.x","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. BAYKAN B, WOLF P. Juvenile myoclonic epilepsy as a spectrum disorder: a focused review. Seizure 2017; 49: 36-41. https:\/\/doi.org\/10.1016\/j.seizure.2017.05.011","DOI":"10.1016\/j.seizure.2017.05.011"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. GELISSE P, GENTON P, THOMAS P, REY M, SAMUELIAN JC, DRAVET C. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 2001; 70: 240-243. https:\/\/doi.org\/10.1136\/jnnp.70.2.240","DOI":"10.1136\/jnnp.70.2.240"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. MART\u00cdNEZ-JU\u00c1REZ IE, ALONSO ME, MEDINA MT, DUR\u00d3N RM, BAILEY JN, L\u00d3PEZ-RUIZ M et al. Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain 2005; 129: 1269-1280. https:\/\/doi.org\/10.1093\/brain\/awl048","DOI":"10.1093\/brain\/awl048"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. SU YH, IZUMI T, KITSU M, FUKUYAMA Y. Seizure threshold in juvenile myoclonic epilepsy with Graves disease. Epilepsia 1993; 34: 488-492. https:\/\/doi.org\/10.1111\/j.1528-1157.1993.tb02589.x","DOI":"10.1111\/j.1528-1157.1993.tb02589.x"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. BAYKAN B, MART\u00cdNEZ-JU\u00c1REZ IE, ALTINDAG EA, CAMFIELD CS, CAMFIELD PR. Lifetime prognosis of juvenile myoclonic epilepsy. Epilepsy Behav 2013; 28: S18-S24. https:\/\/doi.org\/10.1016\/j.yebeh.2012.06.036","DOI":"10.1016\/j.yebeh.2012.06.036"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. ARNTSEN V, SAND T, SYVERTSEN MR, BRODTKORB E. Prolonged epileptiform EEG runs are associated with persistent seizures in juvenile myoclonic epilepsy. Epilepsy Res 2017; 134: 26-32. https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.05.003","DOI":"10.1016\/j.eplepsyres.2017.05.003"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. JAIN S, PADMA MV, MAHESHWARI MC. Occurrence of only myoclonic jerks in juvenile myoclonic epilepsy. Acta Neurol Scand 1997; 95: 263-267. https:\/\/doi.org\/10.1111\/j.1600-0404.1997.tb00207.x","DOI":"10.1111\/j.1600-0404.1997.tb00207.x"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. HEALY L, MORAN M, SINGHAL S, O'DONOGHUE MF, ALZOUBIDI R, WHITEHOUSE WP. Relapse after treatment withdrawal of antiepileptic drugs for Juvenile Absence Epilepsy and Juvenile Myoclonic Epilepsy. Seizure 2018; 59: 116-122. https:\/\/doi.org\/10.1016\/j.seizure.2018.05.015","DOI":"10.1016\/j.seizure.2018.05.015"}],"container-title":["Anales del Sistema Sanitario de Navarra"],"original-title":[],"link":[{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/74332\/49218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T05:57:21Z","timestamp":1749189441000},"score":1,"resource":{"primary":{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/74332\/49218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,4]]}},"URL":"https:\/\/doi.org\/10.23938\/assn.0756","relation":{},"ISSN":["1137-6627"],"issn-type":[{"value":"1137-6627","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,20]]}}}